This article will look at what GLP-1s are, how they work for diabetes and weight loss, new GLP-1 uses in the treatment of other conditions, and how Vital can offer expertise and practical advice on optimizing GLP-1 programs with wearable data and lab testing
Cognitive & Neuroprotective Effects This is an emerging but genuinely interesting area of GHK-Cu research
If in 2026 and 2027 we collect information that shows that GLP-1 agonist semaglutides are being abused in sport, they could be banned before the Los Angeles Olympics, Professor Rabin revealed, confirming WADA will continue to monitor for possible misuse of semaglutide in-competition and out-of-competition in 2026 along with other drugs such as tirzepatide, another diabetes medication
Cell Death Dis (2013) 4:e612
Headaches or difficulty concentrating
Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks: CJC-1295